US brand comparison

Ozempic vs Zepbound

Last updated

Ozempic contains semaglutide. Zepbound contains tirzepatide. Compare approved uses, formulations, and self-pay prices.

Ozempic vs Zepbound: the lowest prices now

Ozempic vs Zepbound: active ingredients, formulations, and manufacturers
CompareOzempicZepbound
Active ingredientSemaglutideGLP-1TirzepatideGIP/GLP-1
How it is taken

Injection

Once weekly

Tablet

Once daily, on an empty stomach

Injection

Once weekly

ManufacturerNovo NordiskEli Lilly
Direct evidence

What was actually compared

No direct trial comparing these exact brands is included in our reviewed catalog. Results from separate trials are not a direct comparison of these products.

Weight-loss results by formulation

Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.

Ozempic vs Zepbound: sourced weight-loss results by formulation
CompareOzempicZepbound
Injection evidence

No reviewed weight-loss result for this brand and formulation.

−20.9% (nejm.org/doi/full/10.1056/NEJMoa2206038) (-20.9% at 72 wks · SURMOUNT-1 · 15 mg weekly (Zepbound))

SURMOUNT-1 · -20.9% at 72 wks (nejm.org)

15 mg weekly (Zepbound)

Accounts for treatment discontinuation

Tablet evidence

No reviewed weight-loss result for this brand and formulation.

No reviewed weight-loss result for this brand and formulation.

Product-specific costs

Entry price and maintenance price

Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.

Ozempic vs Zepbound: published self-pay prices by formulation
CompareOzempicZepbound
Injection prices

Advertised entry price

$199/fill initially (novocare.com/pharmacy/ozempic.html)

28-day supply (novocare.com)

≈ $213.21 per 30 days at this quoted rate

Offer through

Checked on novocare.com

Ozempic pen

NovoCare (Novo Nordisk) · maker's own price

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"

Price conditions

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"

After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Published maintenance dose

$499/28 days (novocare.com/eligibility/ozempic-pharmacy.html)

28-day supply (novocare.com)

≈ $534.64 per 30 days at this quoted rate

Checked on novocare.com

At 2 mg

Ozempic pen

NovoCare (Novo Nordisk) · maker's own price

Published price at 2 mg

Price conditions

Published price at 2 mg

After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Advertised entry price

$299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

28-day supply (zepbound.lilly.com)

≈ $320.36 per 30 days at this quoted rate

Checked on zepbound.lilly.com

Zepbound KwikPen (multi-dose pen)

LillyDirect (Eli Lilly) · maker's own price

self-pay cash, by dose ($299 / $399 / $449)

Price conditions

self-pay cash, by dose ($299 / $399 / $449)

Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

28-day supply

Published maintenance dose

$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

28-day supply (zepbound.lilly.com)

≈ $481.07 per 30 days at this quoted rate

Checked on zepbound.lilly.com

At 15 mg

Zepbound KwikPen (multi-dose pen)

LillyDirect (Eli Lilly) · maker's own price

Published price at 15 mg

Price conditions

Published price at 15 mg

Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

28-day supply

Tablet prices

Advertised entry price

$149/30 days (novocare.com/pharmacy/ozempic.html)

30-day supply (novocare.com)

$149 per 30 days at this quoted rate

Checked on novocare.com

Ozempic tablets

NovoCare (Novo Nordisk) · maker's own price

self-pay, 1.5 mg dose

Price conditions

self-pay, 1.5 mg dose

A prescription is required. A bottle of 30 tablets costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits.

30-day supply

Published maintenance dose

$299/30 days (novocare.com/eligibility/ozempic-pharmacy.html)

30-day supply (novocare.com)

$299 per 30 days at this quoted rate

Checked on novocare.com

At 9 mg

Ozempic tablets

NovoCare (Novo Nordisk) · maker's own price

Published price at 9 mg

Price conditions

Published price at 9 mg

A prescription is required. A bottle of 30 tablets costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits.

30 tablets per bottle. The 4 mg strength costs $199 per 30-day fill; 9 mg costs $299.

30-day supply

No reviewed tablet formulation in this brand record.

How these quotes are selected

For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology

From each FDA label

Ozempic vs Zepbound side effects

Rate on the medicine, with the placebo rate in brackets, at the highest dose in each label's table. These come from separate trials, so they are not a head-to-head comparison.

Side effectOzempic 1 mgZepbound 15 mg
Nausea20.3% (6.1%)28% (8%)
Diarrhea8.8% (1.9%)23% (8%)
Vomiting9.2% (2.3%)13% (2%)
Constipation3.1% (1.5%)11% (5%)
Abdominal pain5.7% (4.6%)10% (5%)
Indigestionnot in table10% (4%)
Fatiguenot in table7% (3%)
Dizzinessnot in table4% (2%)
Injection site reactionsnot in table8% (2%)
Burpingnot in table5% (1%)
Refluxnot in table5% (2%)
Gasnot in table4% (2%)
Bloatingnot in table4% (2%)
Hair lossnot in table5% (1%)
From FDA and CMS records

Ozempic vs Zepbound: timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Ozempic2 mg from week 13about 1 weekNot yet: tentative onlyDec 5, 20312,044,798
Zepbound15 mg from week 21about 5-6 daysNoMay 13, 2036160,298

How long each takes · Generics and patents · Who covers what

US prescribing information

Approved uses by formulation

Eligibility, contraindications, and warnings are in each product's full prescribing information.

Ozempic vs Zepbound: reviewed approved uses by formulation
CompareOzempicZepbound
Injection

Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease.

US prescribing information (novo-pi.com) (Ozempic Injection prescribing information)

Reviewed Nov 4, 2026

Weight management in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity.

US prescribing information (pi.lilly.com) (Zepbound Injection prescribing information)

Reviewed Nov 4, 2026

Tablet

Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.

US prescribing information (novo-pi.com) (Ozempic Tablet prescribing information)

Reviewed Nov 4, 2026

No reviewed tablet label in this brand record. Ingredient record

Full evidence and safety information

Compare the active ingredients
Updated automatically

What changed for Ozempic and Zepbound

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Ozempic vs Zepbound: common questions

Is Ozempic the same as Zepbound?

No. Ozempic contains semaglutide and Zepbound contains tirzepatide, which are different medicines.

Is Ozempic or Zepbound safer?

We know of no trial set up to answer that. Stopping because of side effects, each in its own trial and not a head-to-head figure: Ozempic 7.0% vs 3.1% placebo (STEP 1 (2.4 mg, 68 wks, obesity)) (nejm.org); Zepbound 6.2% vs 2.6% placebo (15 mg) (SURMOUNT-1 (15 mg, 72 wks, obesity)) (nejm.org). Each FDA label lists its own warnings, and which ones matter depends on your health. Side effects compared, from each FDA label

What Zepbound dose is equivalent to Ozempic?

No FDA label sets a dose of Ozempic that equals a dose of Zepbound, and we know of no trial that defines one. Switching is a prescriber's decision, and each label sets its own starting dose and steps. Each label's doses and steps

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.